From: Bronchial thermoplasty in severe asthma: a real-world study on efficacy and gene profiling
Demographic and Clinical Characteristics | T0 |
---|---|
No. of patients | 27 |
Age y, mean ± SD | 52 ± 10 |
Female, n (%) | 14 (52) |
Age onset y, mean ± SD | 36 ± 12 |
Ex smokers, n (%) | 5 (18) |
Atopics, n (%) | 6 (22) |
Switch from Omalizumab, n (%) | 5 (18) |
Phenotypes | |
 T2-high, n (%) | 13 (48) |
 Eosinophilic, n (%) | 7 (26) |
 Eosinophilic and Allergic, n (%) | 3 (11) |
 Only Allergic, n (%) | 3 (11) |
 T2-low, n (%) | 14 (52) |
 Neutrophilic, n (%) | 14 (52) |
Comorbidities | |
 Gastroesophageal reflux disease (GERD), n (%) | 14 (52) |
 Chronic rhinosinusitis with nasal polyps (CRSwNP), n (%) | 9 (33) |
BT Activations mean (SD) | 193 ± 39 |